Investor Relations Corporate Profile Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. RECENT NEWS October 16, 2019 Evolus and Clarion Medical Technologies Announce First Shipment of Nuceiva™ (prabotulinumtoxinA) to Customers in Canada October 1, 2019 Evolus Receives Approval for Nuceiva™ in the European Union September 18, 2019 Evolus will Participate in Cantor Global Healthcare Conference View all EVENTS 2019 Cantor Global Healthcare Conference Oct 2, 2019 at 11:15 AM EDT H.C. Wainwright 21st Annual Global Investment Conference: Sep 9, 2019 at 1:20 PM EDT Wells Fargo Securities 2019 Healthcare Conference: Sep 4, 2019 at 10:15 AM EDT View all PRESENTATIONS October 2019 Investor Presentation Oct 02, 2019 September 2019 Investor Presentation Sep 04, 2019 August 2019 Investor Presentation Aug 12, 2019
October 16, 2019 Evolus and Clarion Medical Technologies Announce First Shipment of Nuceiva™ (prabotulinumtoxinA) to Customers in Canada